TY - JOUR
T1 - Morphological and biochemical evidence of protective effect by ONO-3144, a free radical scavenger, on the reoxygenation injury in the anoxic myocardium
AU - Ashraf, M.
AU - Kobayashi, H.
AU - Rahamathylla, P. M.
N1 - Copyright:
Copyright 2004 Elsevier B.V., All rights reserved.
PY - 1989
Y1 - 1989
N2 - We have investigated the effect of ONO-3144 (2:aminomethyl-4-tert-butyl-propionylphenol), which accelerates the conversion of prostaglandin G2 to H2 and acts as a scavenger for free radicals, on the reoxygenation injury in the anoxic heart. Rat hearts were perfused retrogradely with Krebs-Henseleit (KH) medium for 30 minutes in Group I. In Group II, the hearts which were perfused with anoxic KH medium for 40 minutes were reoxygenated for 30 minutes. Group III was similar for Group II except that 4 mg ONO-3144/liter was added in anoxic medium. Group IV was similar to group III except ONO-3144 was present both during anoxia and reoxygenation. Coronary effluent was collected for the measurement of creatine phosphokinase (CPK). Tissue from each group was processed for electron microscopy, adenosine triphosphate (ATP), and tissue calcium. A six-fold increase in CPK leakage that was observed after reoxygenation of anoxic heart was prevented by ONO-3144. Tissue ATP was reduced from 21.65 ± 1.1 μmol/gm dry weight (Group I) to 4.83 ± 0.8 μmol/gm dry weight (Group II). A significant amount of ATP (9.05 ± 1.22 μmol/gm dry weight) was preserved in the treated Group IV. The number of normal cells obtained by morphological analysis increased significantly from 24.2 ± 8.4% (Group II) to 70.00 ± 4.0% (Group IV), and severely injured cells were also reduced to 19.8 ± 2.8% in the same group as compared to 54.8% in the untreated Group II. At the electron microscopic level, the cellular membranes, mitochondria, vascular endothelium, and glycogen deposits were well preserved in Group IV. The treatment during anoxia only did not minimize the reoxygenation damage (Group III). Thus, treatment with ONO-3144 provides a great protection against reoxygenation injury to the myocyte and vascular endothelium of the anoxic myocardium, perhaps by scavenging active oxygen species.
AB - We have investigated the effect of ONO-3144 (2:aminomethyl-4-tert-butyl-propionylphenol), which accelerates the conversion of prostaglandin G2 to H2 and acts as a scavenger for free radicals, on the reoxygenation injury in the anoxic heart. Rat hearts were perfused retrogradely with Krebs-Henseleit (KH) medium for 30 minutes in Group I. In Group II, the hearts which were perfused with anoxic KH medium for 40 minutes were reoxygenated for 30 minutes. Group III was similar for Group II except that 4 mg ONO-3144/liter was added in anoxic medium. Group IV was similar to group III except ONO-3144 was present both during anoxia and reoxygenation. Coronary effluent was collected for the measurement of creatine phosphokinase (CPK). Tissue from each group was processed for electron microscopy, adenosine triphosphate (ATP), and tissue calcium. A six-fold increase in CPK leakage that was observed after reoxygenation of anoxic heart was prevented by ONO-3144. Tissue ATP was reduced from 21.65 ± 1.1 μmol/gm dry weight (Group I) to 4.83 ± 0.8 μmol/gm dry weight (Group II). A significant amount of ATP (9.05 ± 1.22 μmol/gm dry weight) was preserved in the treated Group IV. The number of normal cells obtained by morphological analysis increased significantly from 24.2 ± 8.4% (Group II) to 70.00 ± 4.0% (Group IV), and severely injured cells were also reduced to 19.8 ± 2.8% in the same group as compared to 54.8% in the untreated Group II. At the electron microscopic level, the cellular membranes, mitochondria, vascular endothelium, and glycogen deposits were well preserved in Group IV. The treatment during anoxia only did not minimize the reoxygenation damage (Group III). Thus, treatment with ONO-3144 provides a great protection against reoxygenation injury to the myocyte and vascular endothelium of the anoxic myocardium, perhaps by scavenging active oxygen species.
UR - http://www.scopus.com/inward/record.url?scp=0024427268&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024427268&partnerID=8YFLogxK
M3 - Article
C2 - 2789807
AN - SCOPUS:0024427268
SN - 0887-8005
VL - 2
SP - 351
EP - 364
JO - American Journal of Cardiovascular Pathology
JF - American Journal of Cardiovascular Pathology
IS - 4
ER -